Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
NCT02090465
·
clinicaltrials.gov ↗
COMPLETED
Status
840
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
Ingenol Mebutate
Sponsor
LEO Pharma